Both anemia and blood transfusions present potential risks to patients having cardiac surgery. Patient Blood Management (PBM) aims to reduce blood transfusions and their associated risks by optimizing the patient’s own blood supply, ensuring efficient use of blood products, and implementing strategies to minimize blood loss. It contributes to improved patient safety, better clinical outcomes, and cost savings in cardiac surgery.
Anemia can negatively affect the recovery process in patients undergoing cardiac surgery through a variety of mechanisms:
Decreased Oxygen Delivery:
- Anemic patients have reduced oxygen-carrying capacity, which can lead to decreased oxygen delivery to tissues and organs, resulting in organ dysfunction and injury.
Increased Morbidity and Mortality:
- Studies have shown that anemic patients undergoing cardiac surgery are at a higher risk of morbidity and mortality. They experience increased rates of infections, longer hospital stays, and higher incidences of postoperative complications.
Although blood transfusions can address anemia by increasing the red blood cell count, they also come with their own risks:
- Transfusion Reactions
- Increased risk of infection
- Increased risk of kidney injury
- Fluid overload
- Transfusion-Related Acute Lung Injury (TRALI)
Principles of Patient Blood Management in Cardiac Surgery:
Preoperative Optimization:
- Identify and treat anemia before surgery to improve red blood cell count and oxygen-carrying capacity.
- Ensure that the patient has adequate levels of essential nutrients like iron, vitamin B12, and folate.
- Stop antiplatelet and anticoagulant medications for the appropriate duration.
Intraoperative Conservation:
- Use of anti-fibrinolytics.
- Use of advanced surgical techniques and technologies to limit blood loss during the operation.
- Collect, filter, and return the patient’s own blood lost during surgery.
- Point-of-care testing to assess and treat coagulopathy.
- Hemodilution to preserve red cell mass.
- Use evidence-based criteria to decide when transfusions are necessary.
Postoperative Recovery:
- Avoid hypothermia.
- Keep track of blood loss and manage bleeding promptly.
- Use evidence-based criteria to decide when transfusions are necessary.
Benefits of Patient Blood Management:
- Reduced need for transfusions
- Improved patient outcomes
- Cost-effectiveness
- Resource conservation
____________________________________________________________________________________________________________________________
This summary was written with assistance from artificial intelligence. All text was reviewed, edited, and supplemented by the listed editor(s). Reference: OpenAI. (2023). ChatGPT (Sept 25 version) [Large language model]. https://chat.openai.com/chat
ERAS Cardiac VTC Disclaimer:
The VTC, and all included content, is intended to inform ERAS Cardiac Members in a multitude of topics related to enhanced recovery. The information included has been provided by other enhanced recovery experts and should be used for educational purposes only. It is not intended to describe, recommend, or suggest any specific medical practice or intervention, nor should it be considered as formal medical advice or consultation. The ERAS Cardiac Society cannot guarantee that the information on the VTC is accurate or complete in every respect. Therefore, ERAS Cardiac Society is not responsible for any errors or omissions in the content, or medical results that occur with the application of the information obtained while using the VTC. All healthcare professionals should continue to use sound clinical judgment and prescribe therapies based on the best medical knowledge at their disposal.
All the material presented on the VTC is the intellectual property of the ERAS Cardiac Society, its contributors, and its sponsors. Unless explicitly stated, the information, images, audio, video, and other content may not be reproduced (in whole or in part) in any way without the written permission of the ERAS Cardiac Society.
If you have any questions or comments about the ERAS Cardiac VTC, please email: VTC@erascardiac.org
Pre-op Anemia: Is it Worth Fixing?
Dr. Salenger reviews the evidence for detecting and correcting anemia pre-operatively.
ERAS Controversies: Should EPO be Used Pre-op to Correct Anemia?
This video is a recording of a previous ERAS Cardiac webinar held in conjunction with CTSNet. Please visit CTSNet [https://www.ctsnet.org] for additional educational content. Speakers and discussants include members of our international network of ERAS experts. In this session, participants discuss controversies regarding the use of erythropoietin stimulating agents (ESAs) to correct anemia prior to cardiac surgery.
Patient Blood Management: Beyond Pre-op Optimization
This video by Amanda Rea reviews the key aspects of patient blood management (PBM) beyond correcting anemia pre-operatively.
Bloodless Surgery: Treating All Patients as if they were Jehovah's Witness
Dr. Salenger reviews the methods which have been developed over the years to treat patients who decline blood transfusion, and why these should be applied to all patients.
PBM 1: Strategies to Reduce Transfusion
This video is a recorded session from the ERAS Cardiac Virtual Meeting in 2021. Speakers and discussants include members of our international network of ERAS experts. In this session, participants discuss strategies to reduce blood transfusion.
PBM 2: Transfusion Thresholds
This video is a recorded session from the ERAS Cardiac Virtual Meeting in 2021. Speakers and discussants include members of our international network of ERAS experts. In this session, participants discuss the evidence and approach to establishing transfusion thresholds in cardiac surgery.
Addressing Bleeding Challenges in Surgery
Dr. Tippit reviews techniques to quantify bleeding severity in an objective and reproducible fashion with the VIBe Bleeding Scale. [Sponsored]
Addressing Intra-operative Hemostatic Challenges for Reducing Bleeding Complications.
Dr. Mayya builds on the previous presentation on the VIBe Bleeding Scale. He covers how the degree of bleeding, in conjunction with laboratory features of coagulopathy can assist in determining the best topical hemostatic options. He also discusses the evidence for the impact of topical hemostatic agents on blood loss in cardiac surgery. [Sponsored]
Real World Applications of PBM in Cardiac Surgery
This video is a recording of a previous ERAS Cardiac webinar held in conjunction with CTSNet. Please visit CTSNet [https://www.ctsnet.org] for additional educational content. Speakers and discussants include members of our international network of ERAS experts. In this session, participants discuss topics regarding PBM. Included are pre-operative correction of anemia, ways to quantify bleeding severity, point-of care coagulation testing, and topical hemostatic agents.
Fibrinogen Replacement in Cardiac Surgery
Dr. Keeyapaj, a cardiac anesthesiologist from Stanford University, reviews the role of fibrinogen concentrate utilization in cardiac surgery. [Sponsored]